Search
Tempus AI Inc
TEMAdd to Watchlist
51.940USD
+3.330+6.85%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
9.33BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+6.85%
5 Days
+6.46%
1 Month
+12.47%
6 Months
-19.17%
Year to Date
-12.04%
1 Year
-23.93%
Key Figures
48.710Open
52.560High
6.97MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
3.91%Turnover Ratio
48.610Prev. Close
48.450Low
261.93MTurnover
LossP/E Static
18.85P/B
0.00%Div Yield TTM
-16.47%ROA
104.32052wk High
1.18Volume Ratio
-746.33MNet Profit
178.28MShares
-1.7110EPS TTM
--Beta
-81.58%ROE
41.73052wk Low
8.46%Amplitude
63.78%Gross Margin
9.33BMarket Cap
1.06Reward/Risk
3.94%Risk Rate
TradingKey Stock Score of Tempus AI Inc
Currency: USD Updated: 2026-06-24Key Insights
Tempus AI Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 62 out of 388 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 70.96.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Tempus AI Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Tempus AI Inc Highlights
StrengthsRisks
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 139.14% year-on-year.
Undervalued
The company’s latest PE is -30.36, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 109.28M shares, increasing 5.45% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 9.21M shares of this stock.
Analyst Rating
Based on
20
analysts
Buy
Current Rating
70.963
Target Price
+39.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Tempus AI Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Tempus AI Inc Info
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Ticker SymbolTEM
CompanyTempus AI Inc
CEOLefkofsky (Eric P)
Websitehttps://investors.tempus.com/
Related Instruments
+0.90%
+0.82%
+0.08%
-0.14%
+0.88%
+0.83%
+1.27%
-0.02%
+0.09%
-2.71%
+1.45%
-0.89%
-1.86%
-0.65%
+0.41%
0.00%
+0.87%
+1.80%
-0.11%
-0.76%Popular Instruments
FAQs
What is the current price of Tempus AI Inc (TEM)?
The current price of Tempus AI Inc (TEM) is 51.94.
What is the symbol of Tempus AI Inc?
The ticker symbol of Tempus AI Inc is TEM.
What is the 52-week high of Tempus AI Inc?
The 52-week high of Tempus AI Inc is 104.32.
What is the 52-week low of Tempus AI Inc?
The 52-week low of Tempus AI Inc is 41.73.
What is the market capitalization of Tempus AI Inc?
The market capitalization of Tempus AI Inc is 9.26B.
Is Tempus AI Inc (TEM) currently rated as Buy, Hold, or Sell?
According to analysts, Tempus AI Inc (TEM) has an overall rating of Buy, with a price target of 70.96.
What is the Earnings Per Share (EPS TTM) of Tempus AI Inc (TEM)?
The Earnings Per Share (EPS TTM) of Tempus AI Inc (TEM) is -1.41.
